Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-02-24 Sale |
2025-02-25 8:36 pm |
KalVista Pharmaceuticals Inc. | KALV | Yea Christopher CHIEF DEVELOPMENT OFFICER |
1,918 | $10.02 | $19,218 | 194,577 (Direct) |
View |
| 2025-02-18 Sale |
2025-02-19 8:47 pm |
KalVista Pharmaceuticals Inc. | KALV | Yea Christopher CHIEF DEVELOPMENT OFFICER |
2,601 | $9.8242 | $25,553 | 108,906 (Direct) |
View |
| 2024-11-26 Sale |
2024-11-27 8:43 pm |
KalVista Pharmaceuticals Inc. | KALV | Yea Christopher CHIEF DEVELOPMENT OFFICER |
1,963 | $9.8718 | $19,378 | 134,892 (Direct) |
View |
| 2024-11-18 Sale |
2024-11-19 7:18 pm |
KalVista Pharmaceuticals Inc. | KALV | Yea Christopher CHIEF DEVELOPMENT OFFICER |
7,192 | $9.2565 | $66,573 | 110,345 (Direct) |
View |
| 2024-08-23 Sale |
2024-08-26 7:58 pm |
KalVista Pharmaceuticals Inc. | KALV | Yea Christopher CHIEF DEVELOPMENT OFFICER |
1,916 | $12.4 | $23,758 | 132,551 (Direct) |
View |
| 2024-08-19 Sale |
2024-08-21 9:25 pm |
KalVista Pharmaceuticals Inc. | KALV | Yea Christopher CHIEF DEVELOPMENT OFFICER |
7,102 | $12.01 | $85,318 | 116,328 (Direct) |
View |
| 2024-05-20 Sale |
2024-05-21 5:55 pm |
KalVista Pharmaceuticals Inc. | KALV | Yea Christopher CHIEF DEVELOPMENT OFFICER |
11,610 | $11.76 | $136,586 | 123,430 (Direct) |
View |
| 2024-02-20 Sale |
2024-02-21 9:48 pm |
KalVista Pharmaceuticals Inc. | KALV | Yea Christopher CHIEF DEVELOPMENT OFFICER |
12,053 | $14.11 | $170,124 | 142,332 (Direct) |
View |
| 2024-02-14 Sale |
2024-02-16 4:18 pm |
KalVista Pharmaceuticals Inc. | KALV | Yea Christopher CHIEF DEVELOPMENT OFFICER |
39,886 | $15.01 | $598,661 | 66,160 (Direct) |
View |
| 2023-11-20 Sale |
2023-11-21 4:32 pm |
KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer |
7,113 | $8.2293 | $58,535 | 83,228 (Direct) |
View |
| 2023-08-18 Sale |
2023-08-21 8:06 pm |
KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer |
7,142 | $10.73 | $76,624 | 83,049 (Direct) |
View |
| 2023-05-18 Sale |
2023-05-19 9:20 pm |
KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer |
2,604 | $10.14 | $26,416 | 112,066 (Direct) |
View |
| 2023-02-17 Sale |
2023-02-23 5:42 pm |
KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer |
2,727 | $7.66 | $20,889 | 58,768 (Direct) |
View |
| 2022-11-18 Sale |
2022-11-21 4:21 pm |
KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer |
1,139 | $5.44 | $6,196 | 59,065 (Direct) |
View |
| 2022-08-17 Sale |
2022-08-19 5:16 pm |
KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer |
1,145 | $14.96 | $17,130 | 60,204 (Direct) |
View |
| 2021-11-01 Sale |
2021-11-03 4:56 pm |
KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer |
5,000 | $18.07 | $90,328 | 32,969 (Direct) |
View |
| 2021-08-02 Sale |
2021-08-04 7:55 pm |
KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer |
5,000 | $20.52 | $102,579 | 37,969 (Direct) |
View |
| 2021-05-03 Sale |
2021-05-06 8:06 pm |
KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer |
5,000 | $24.84 | $124,197 | 42,969 (Direct) |
View |
| 2021-02-23 Sale |
2021-02-25 8:25 pm |
KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer |
15,000 | $33.59 | $503,877 | 47,969 (Direct) |
View |
| 2020-10-29 Sale |
2020-11-02 8:01 pm |
KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer |
5,000 | $17.48 | $87,394 | 62,969 (Direct) |
View |
| 2020-10-20 Sale |
2020-10-22 5:36 pm |
KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer |
13,986 | $17.82 | $249,167 | 67,969 (Direct) |
View |
| 2020-10-16 Sale |
2020-10-20 2:14 pm |
KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer |
914 | $17 | $15,539 | 81,955 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-21 Option Award |
2025-02-25 8:36 pm |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Yea Christopher CHIEF DEVELOPMENT OFFICER |
60,000 | $0 | 194,577 (Direct) |
View |
| 2025-02-22 Exercise |
2025-02-25 8:36 pm |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Yea Christopher CHIEF DEVELOPMENT OFFICER |
3,125 | $0 | 194,577 (Direct) |
View |
| 2025-02-17 Exercise |
2025-02-19 8:47 pm |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Yea Christopher CHIEF DEVELOPMENT OFFICER |
8,408 | $0 | 108,906 (Direct) |
View |
| 2024-11-22 Exercise |
2024-11-27 8:43 pm |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Yea Christopher CHIEF DEVELOPMENT OFFICER |
3,125 | $0 | 134,892 (Direct) |
View |
| 2024-11-17 Exercise |
2024-11-19 7:18 pm |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Yea Christopher CHIEF DEVELOPMENT OFFICER |
22,992 | $0 | 110,345 (Direct) |
View |
| 2024-08-22 Exercise |
2024-08-26 7:58 pm |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Yea Christopher CHIEF DEVELOPMENT OFFICER |
3,125 | $0 | 132,551 (Direct) |
View |
| 2024-08-17 Exercise |
2024-08-21 9:25 pm |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Yea Christopher CHIEF DEVELOPMENT OFFICER |
22,990 | $0 | 116,328 (Direct) |
View |
| 2024-05-22 Option Award |
2024-05-24 4:10 pm |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Yea Christopher CHIEF DEVELOPMENT OFFICER |
50,000 | $0 | 50,000 (Direct) |
View |
| 2024-05-17 Exercise |
2024-05-21 5:55 pm |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Yea Christopher CHIEF DEVELOPMENT OFFICER |
37,578 | $0 | 123,430 (Direct) |
View |
| 2024-02-17 Exercise |
2024-02-21 9:48 pm |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Yea Christopher CHIEF DEVELOPMENT OFFICER |
37,576 | $0 | 142,332 (Direct) |
View |
| 2024-02-11 Option Award |
2024-02-13 09:11 am |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Yea Christopher CHIEF DEVELOPMENT OFFICER |
89,167 | $0 | 135,213 (Direct) |
View |
| 2023-11-17 Exercise |
2023-11-21 4:32 pm |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer |
22,994 | $0 | 83,228 (Direct) |
View |
| 2023-08-17 Exercise |
2023-08-21 8:06 pm |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer |
22,988 | $0 | 83,049 (Direct) |
View |
| 2023-02-17 Exercise(A) |
2023-05-22 9:40 pm |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer |
2,430 | $0 | 26,736 (Direct) |
View |
| 2023-01-11 Option Award |
2023-05-19 9:20 pm |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer |
29,166 | $0 | 112,066 (Direct) |
View |
| 2023-05-17 Exercise |
2023-05-19 9:20 pm |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer |
8,410 | $0 | 112,066 (Direct) |
View |
| 2023-02-17 Exercise |
2023-02-23 5:42 pm |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer |
8,408 | $0 | 58,768 (Direct) |
View |
| 2022-11-17 Exercise |
2022-11-21 4:21 pm |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer |
1,774 | $0 | 59,065 (Direct) |
View |
| 2022-08-17 Exercise |
2022-08-19 5:16 pm |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer |
1,773 | $0 | 60,204 (Direct) |
View |
| 2022-05-17 Option Award |
2022-05-19 4:57 pm |
N/A 2032-05-16 |
KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer |
47,300 | $0 | 47,300 (Direct) |
View |
| 2021-05-26 Option Award |
2021-05-28 5:26 pm |
N/A 2031-05-25 |
KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer |
60,000 | $0 | 60,000 (Direct) |
View |
| 2021-02-07 Option Award |
2021-02-08 9:35 pm |
N/A 2029-05-15 |
KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer |
51,000 | $0 | 51,000 (Direct) |
View |
| 2020-12-16 Option Award |
2020-12-18 6:13 pm |
N/A 2030-06-16 |
KalVista Pharmaceuticals Inc. | KALV | Yea Christopher Chief Development Officer |
80,000 | $0 | 80,000 (Direct) |
View |